Intra-Cellular Therapies, Inc. (ITCI) — Analyst outlook / Analyst consensus target is. Based on 23 analyst ratings, the consensus is bullish — 14 Buy, 9 Hold.
The consensus price target is $132.00, representing an upside of 0.1% from the current price $131.87.
ITCI Stock — 12-Month Price Forecast
$132.00
▲ +0.10% Upside
Average Price Target
Based on 23 Wall Street analysts offering 12-month price targets for Intra-Cellular Therapies, Inc., the price target is $132.00.
The average price target represents a +0.10% change from the last price of $131.87.
ITCI Analyst Ratings
Buy
Based on 23 analysts giving stock ratings to Intra-Cellular Therapies, Inc. in the past 3 months
